Prescriber's Corner
Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
Derek Peterson, PharmD(c), and Joanna Schwartz, BCOP, PharmD
Albany College of Pharmacy and Health Sciences, Colchester, Vermont, and Fletcher Allen Healthcare, Burlington, Vermont
Derek Peterson, PharmD(c),
261 Mountain View Drive, Colchester, VT 05446.
E-mail: derek.peterson@acphs.edu
J Adv Pract Oncol 2014;5:348–354 |
DOI: 10.6004/jadpro.2014.5.5.5 |
© 2014 Harborside Press®
For access to the full length article, please
sign in.
